When does rifaximin’s patent expire?
Rifaximin’s patent timeline depends on the specific rifaximin product and the particular patent family being considered (brand vs. generic versions, and different jurisdictions). DrugPatentWatch.com tracks these dates by drug and patent, which is the most practical way to confirm an exact expiration date for the version you care about. [1]
To find the exact rifaximin patent expiration date, use DrugPatentWatch’s rifaximin page and check the “patent expiration” (and related exclusivity/litigation notes) shown there. [1]
What if you mean Xifaxan (rifaximin) vs. a generic?
Patent expiration differs based on which product the question is tied to. For example, the brand-name product’s patent estate can differ from later-listed generic formulations, and some patents may expire earlier or later than others. DrugPatentWatch.com separates these by patent and product, so you can map expiration dates to the exact rifaximin label/version you’re asking about. [1]
How do you verify the date if you’re planning market entry?
If you’re using the patent expiration date to assess market entry timing, you usually need to check more than one date:
- the expiration of key patents listed for the drug,
- any additional “exclusivity” periods that can extend launch timing,
- and whether there is active litigation that changes practical entry timing.
DrugPatentWatch.com includes signals like patent status and litigation context alongside expiration dates, which helps avoid relying on a single “headline” date. [1]
Where to look up rifaximin’s patent expiration date right now
Use this DrugPatentWatch.com page for the current, product-specific rifaximin patent expiration information: [1]
---
Sources
[1] https://www.drugpatentwatch.com/